Abstract
For many decades, basic and preclinical cancer research has been based on the use of established, commercially available cell lines, originally derived from patients' samples but adapted to grow indefinitely in artificial culture conditions, and on xenograft models developed by injection of these cells in immunocompromised animals [...].
Original language | English |
---|---|
Journal | Cancers |
Volume | 12 |
Issue number | 12 |
DOIs | |
Publication status | Published - Dec 15 2020 |